Related references
Note: Only part of the references are listed.Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality
Elnaz Vafadar Moradi et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
Cristina Valero et al.
NATURE COMMUNICATIONS (2021)
High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
Edmund K. Bartlett et al.
CANCER (2020)
Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis
Jing Jin et al.
BMJ OPEN (2020)
Cohort retrospective study: the neutrophil to lymphocyte ratio as an independent predictor of outcomes at the presentation of the multi-trauma patient
Soulaiman Elias Soulaiman et al.
INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE (2020)
Neutrophils escort circulating tumour cells to enable cell cycle progression
Barbara Maria Szczerba et al.
NATURE (2019)
Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors
Tao Jiang et al.
LUNG CANCER (2019)
Neutrophil-lymphocyte ratio (NLR) predicted prognosis for advanced non-small-cell lung cancer (NSCLC) patients who received immune checkpoint blockade (ICB)
Fangping Ren et al.
ONCOTARGETS AND THERAPY (2019)
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy
Colton J. Ladbury et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer
Dickran Kazandjian et al.
JAMA ONCOLOGY (2019)
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis
Zimu Wang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Validating the use of veterans affairs tobacco health factors for assessing change in smoking status: accuracy, availability, and approach
Anne C. Melzer et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita et al.
JAMA ONCOLOGY (2018)
Unique pattern of neutrophil migration and function during tumor progression
Sima Patel et al.
NATURE IMMUNOLOGY (2018)
Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer
Angel Qin et al.
CLINICAL LUNG CANCER (2017)
Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients
Yu Yu et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients
Sung Yeon Hwang et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis
Xiao-Bin Gu et al.
SCIENTIFIC REPORTS (2015)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Share Paper
